Clinical Significance of Neutrophil-to-lymphocyte Ratio in Endometriosis Adenomyosis and Hysteromyoma
article
OA: closed
CC0
AI-generated summary
This study found the neutrophil-to-lymphocyte ratio was significantly higher in patients with endometriosis, adenomyosis, or hysteromyoma compared to healthy women, suggesting its diagnostic value.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective: To explore the clinical significance of neutrophil-to-lymphocyte ratio( NLR) in endometriosis,adenomyosis and hysteromyoma. Method: 212 cases were enrolled in this study from 2011 to2013,and were divided into four groups,65 cases with endometriosis( group A),72 cases with adenomyosis( group B),75 cases with hysteromyoma( group C) and 70 cases of health women( group D). Leucocyte number,lymphocyte number,CA125 and CA199 were detected and analysed by software SPSS. Sensitivity and speciality were assesed. Result: NLR was obviously higher in group A,group B and group C than that in group D. The differences were statistically significant( P 0. 05). The sensitivity of diagnosis by CA125 showed that group A( 66.154) and group B( 80.556) were much higher than that in group C( 18.667). The differences were statistically significant( P0.05). The sensitivity of diagnosis by CA129 showed that in group A( 33.846) group B( 18.056) group C( 5.333). The differences were statistically significant( P 0.05).Conclusion: NLR is a new index of inflammatory reaction,which has certain value for the diagnosis of patients with endometriosis,adenomyosis or hysteromyoma.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK